Ottawa life-sciences company Avivagen has ceased operations after the embattled firm’s lengthy search for a buyer came up ...
Modeling by Rebecca Sugden et al. (shown below) predicts a significant rise in deaths caused by multidrug-resistant bacteria worldwide by 2050. Failure to develop new antibiotics could compromise our ...
Climate change exacerbates antimicrobial resistance by altering environments where microbes thrive, leading to increased ...
Mining and utilizing andrimid, a novel antibiotic targeting multidrug-resistant bacteria, presents a strategic solution amidst the rise of antibacterial superbugs. The Academic’s mission is simple: ...